JAZZ

NASDAQ

Jazz Pharmaceuticals Plc · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$14.35B

PE Ratio

—

EV to Ebitda

12.1399

Earnings Yield

-2.94%

Revenue (TTM)

$4.27B

Net Income (TTM)

$-356.1M

Revenue (Annual YoY Growth)

4.88%

Revenue (Quarterly YoY Growth)

10.09%

Profit Margin

-8.35%

Return on Equity

-8.79%

Debt to Equity Ratio

1.2567

Dividend Yield

0.00%

All fundamentals

Core11 fields›

Market Cap$14.35B

Revenue TTM$4.27B

Shares Outstanding61.6M

Float60258602

Float Short9.03%

Days To Cover5.8446620824

Short Interest5385198.0

Insider Ownership23.45%

Volume419657

Relative Strength91.4

GARP2551

Growth Estimates17 fields›

Revenue Growth (Annual)4.88%

Revenue Growth (Quarterly YoY)10.09%

Operating Revenue Growth (Annual)0.134841

Operating Revenue Growth (Quarterly YoY)0.095577

3-Year Revenue Growth5.26%

5-Year Revenue Growth12.54%

EPS Growth (Annual)-167.53%

EPS Growth (Quarterly YoY)3.21%

3-Year EPS Growth Rate0.00%

5-Year EPS Growth Rate0.00%

LT EPS Growth Estimates54.87%

EBITDA Growth (Annual)4.38%

EBITDA Growth (Quarterly YoY)20.75%

CFO Growth (Annual)-2.88%

CFO Growth (Quarterly YoY)-9.05%

FCF Growth (Annual)-12.47%

FCF Growth (Quarterly YoY)-24.14%

Operations28 fields›

Revenue TTM$4.27B

Gross Margin TTM72.87%

Gross Margin (Quarterly)73.01%

R&D % of Revenue TTM18.34%

R&D Expenses TTM$782.7M

Operating Margin TTM13.57%

Operating Margin (Quarterly)21.25%

Operating Expenses TTM$2.53B

Profit Margin TTM-8.35%

Profit Margin (Quarterly)16.98%

Net Income TTM$-356.1M

EPS TTM-5.9702

EPS (Quarterly)3.2073

EBIT Margin TTM13.57%

EBIT Margin (Quarterly)21.25%

EBITDA Margin TTM29.89%

EBITDA Margin (Quarterly)36.20%

EBITDA TTM$1.28B

CFO % of Revenue TTM31.77%

CFO % of Revenue (Quarterly)30.26%

CFO TTM$1.36B

Cash Margin16.01%

Capex % of Revenue TTM3.92%

Capital Expenditures$167.3M

FCF % of Revenue TTM27.85%

FCF % of Revenue (Quarterly)24.40%

FCF TTM$1.19B

Fundamental Score6

Efficiency6 fields›

ROE-8.79%

ROA-3.10%

ROIC-3.70%

CROCI12.35%

Stock Comp % (Quarterly)5.91%

Stock Comp % TTM6.82%

Valuation17 fields›

P/E Forward8.4296

P/S Forward2.8068

P/CFO9.2547

P/FCF10.557

EV/EBITDA (TTM)12.1399

EV/EBITDA Forward7.6027

EV/Revenues (TTM)3.6281

EV/Revenues Forward3.4773

EV/CFO9.9053

EV/FCF (TTM)13.0275

Price To Book2.894

Price to Tangible Book-1.8673

Earnings Yield-2.94%

FCF Yield9.47%

Dividend Yield0.00%

Payout Ratio0.00%

Value Score1

Relative to Industry5 fields›

Relative Gross Margin (Quarterly)0.9355

Relative P/S0.4793

Relative P/B0.6484

Relative Dividend Yield0

Relative Debt to Equity3.679

Liquidity15 fields›

Cash Per Share39.7477

Current Ratio1.8578

Cash & ST Assets$2.44B

Total Debt$5.41B

Goodwill & Intangibles$6.26B

Total Assets$11.66B

Total Liabilities$7.34B

Shareholders Equity$4.32B

Debt to Equity1.2567

Debt to Assets46.55%

Interest Expense$279.5M

Times Interest Earned2.0717

CFO to Debt (TTM)0.2432

Debt to EBITDA (TTM)4.3712

Goodwill % of Assets53.68%

Yields5 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield-2.94%

Buyback Yield0.14%

Shareholder Yield1.65%

Options Flow8 fields›

Call Volume143

Put Volume115

Put/Call Ratio0.8041958041958042

Call $ Volume116163.00000000001

Put $ Volume105405

Put/Call $ Ratio0.9073887554556958

Call OI6438

Put OI4059